Mdxhealth

Mdxhealth company information, Employees & Contact Information

Explore related pages

Related company profiles:

Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.

Company Details

Employees
269
Founded
-
Address
15279 Alton Parkway Suite 100, Irvine,ca 92618,united States
Phone
(324)364-2070
Email
in****@****lth.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Irvine, CA
Looking for a particular Mdxhealth employee's phone or email?

Mdxhealth Questions

News

Bio-Techne Announces Exosome Diagnostics Divestiture - Yahoo Finance

Bio-Techne Announces Exosome Diagnostics Divestiture Yahoo Finance

$15M Precision Diagnostics Deal: MDxHealth Acquires ExoDx Prostate Test Business from Bio-Techne - Stock Titan

$15M Precision Diagnostics Deal: MDxHealth Acquires ExoDx Prostate Test Business from Bio-Techne Stock Titan

Bio-Techne takes a hit on Exodx sale to Mdxhealth - BioWorld MedTech

Bio-Techne takes a hit on Exodx sale to Mdxhealth BioWorld MedTech

Earnings call transcript: MDxHealth Q2 2025 sees revenue growth, stock jumps - Investing.com

Earnings call transcript: MDxHealth Q2 2025 sees revenue growth, stock jumps Investing.com

MDxHealth Completes Acquisition of Exosome Diagnostics - TipRanks

MDxHealth Completes Acquisition of Exosome Diagnostics TipRanks

MDxHealth Sees First Operating Profit - Orange County Business Journal

MDxHealth Sees First Operating Profit Orange County Business Journal

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics - Yahoo Finance

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics Yahoo Finance

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne The Manila Times

MDxHealth names Michael Holder to board, CFO Ron Kalfus to depart - Investing.com

MDxHealth names Michael Holder to board, CFO Ron Kalfus to depart Investing.com

Bio-Techne to divest Exosome Diagnostics business to Mdxhealth - TipRanks

Bio-Techne to divest Exosome Diagnostics business to Mdxhealth TipRanks

MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

MDxHealth SA (MDXH) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... Yahoo Finance

Select mdx test for prostate cancer detection added to Cigna insurance coverage - Urology Times

Select mdx test for prostate cancer detection added to Cigna insurance coverage Urology Times

MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance

MDxHealth SA (MDXH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... Yahoo Finance

MDxHealth Reports Half Year 2018 Results - PR Newswire

MDxHealth Reports Half Year 2018 Results PR Newswire

Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com

Bio-techne to sell exosome diagnostics business to mdxhealth Investing.com

MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges - Yahoo Finance

MDxHealth SA (MDXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Challenges Yahoo Finance

What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings - Yahoo Finance

What To Expect From MDxHealth SA (MDXH) Q3 2024 Earnings Yahoo Finance

MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance

MDxHealth SA (MDXH) Q1 2025: Everything You Need to Know Ahead of Earnings Yahoo Finance

MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics - TipRanks

MDxHealth Announces Q2 Results and Strategic Acquisition of Exosome Diagnostics TipRanks

mdxhealth sa reschedules extraordinary general meeting for june 27 - Investing.com

mdxhealth sa reschedules extraordinary general meeting for june 27 Investing.com

MDxHealth’s Liquid Biopsy Test Proven to Be Cost-Effective - Medical Device and Diagnostic industry

MDxHealth’s Liquid Biopsy Test Proven to Be Cost-Effective Medical Device and Diagnostic industry

symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast CNN

MDxHealth Shares Plunge on New Offering - Orange County Business Journal

MDxHealth Shares Plunge on New Offering Orange County Business Journal

MDxHealth provides Q1 2019 business update - PR Newswire

MDxHealth provides Q1 2019 business update PR Newswire

MDxHealth purchases Oncotype DX GPS test for $100m - Medical Device Network

MDxHealth purchases Oncotype DX GPS test for $100m Medical Device Network

MDxHealth Presents Data Supporting Prostate Cancer Tests - Inside Precision Medicine

MDxHealth Presents Data Supporting Prostate Cancer Tests Inside Precision Medicine

MDxHealth stock supported by BTIG as Q2 revenue and guidance impress - Investing.com

MDxHealth stock supported by BTIG as Q2 revenue and guidance impress Investing.com

MDxHealth - Who Doesn’t Love A Good Prostate Exam? (NASDAQ:MDXH) - Seeking Alpha

MDxHealth - Who Doesn’t Love A Good Prostate Exam? (NASDAQ:MDXH) Seeking Alpha

Diagnosing prostate cancer through a £225 urine test - News-Medical

Diagnosing prostate cancer through a £225 urine test News-Medical

Exact Sciences hands over Oncotype prostate cancer test to MDxHealth for $30M upfront - Fierce Biotech

Exact Sciences hands over Oncotype prostate cancer test to MDxHealth for $30M upfront Fierce Biotech

Is MDxHealth SA stock a defensive play in 2025 - Weekly Gains Summary & Real-Time Chart Breakout Alerts - Trung tâm Dự báo KTTV quốc gia

Is MDxHealth SA stock a defensive play in 2025 - Weekly Gains Summary & Real-Time Chart Breakout Alerts Trung tâm Dự báo KTTV quốc gia

MDxHealth Completes Reverse Stock Split - Orange County Business Journal

MDxHealth Completes Reverse Stock Split Orange County Business Journal

MDXH Stock Price and Chart — NASDAQ:MDXH - TradingView

MDXH Stock Price and Chart — NASDAQ:MDXH TradingView

Is MDxHealth SA stock a defensive play in 2025 - 2025 Support & Resistance & Fast Entry High Yield Stock Tips - Trung tâm Dự báo KTTV quốc gia

Is MDxHealth SA stock a defensive play in 2025 - 2025 Support & Resistance & Fast Entry High Yield Stock Tips Trung tâm Dự báo KTTV quốc gia

A Quick Look at Today's Ratings for MDxHealth(MDXH.US), With a Forecast Between $5 to $7 - 富途牛牛

A Quick Look at Today's Ratings for MDxHealth(MDXH.US), With a Forecast Between $5 to $7 富途牛牛

Boost for MDxHealth’s Urology Diagnostics Tests - Orange County Business Journal

Boost for MDxHealth’s Urology Diagnostics Tests Orange County Business Journal

MDxHealth Signs Partnership with LifeLabs to Make SelectMDx Available in Canada - PR Newswire Canada

MDxHealth Signs Partnership with LifeLabs to Make SelectMDx Available in Canada PR Newswire Canada

New Products: Hybrid basket, grabber provides capture, release of multiple stone sizes - Urology Times

New Products: Hybrid basket, grabber provides capture, release of multiple stone sizes Urology Times

Can MDxHealth SA stock deliver strong Q4 earnings - 2025 Technical Patterns & Expert Approved Trade Ideas - Fundação Cultural do Pará

Can MDxHealth SA stock deliver strong Q4 earnings - 2025 Technical Patterns & Expert Approved Trade Ideas Fundação Cultural do Pará

US-based Mdxhealth acquires Exosome Diagnostics from Bio-Techne - Medical Buyer

US-based Mdxhealth acquires Exosome Diagnostics from Bio-Techne Medical Buyer

MDxHealth creates new global commercial team - PMLiVE

MDxHealth creates new global commercial team PMLiVE

MDxHealth SA Hits New 52-Week High of $4.68, Up 314% - Markets Mojo

MDxHealth SA Hits New 52-Week High of $4.68, Up 314% Markets Mojo

MDxHealth Awarded CLIA Certification for Irvine Laboratory - Genetic Engineering and Biotechnology News

MDxHealth Awarded CLIA Certification for Irvine Laboratory Genetic Engineering and Biotechnology News

MDxHealth’s MGMT Methylation Test Selected for Phase III Brain Cancer Trial - Genetic Engineering and Biotechnology News

MDxHealth’s MGMT Methylation Test Selected for Phase III Brain Cancer Trial Genetic Engineering and Biotechnology News

Top Mdxhealth Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant